Abstract

Cardiovascular disease (CVD), encompassing ailments affecting the heart and vascular system, is estimated to contribute to one-third of global mortality, and its prevalence is continuously rising. The etiology of this condition is multifactorial, making it challenging to identify a singular causative factor. Homocysteine, a factor identified in the 1990s, is known to contribute to the development of atherosclerotic vascular disease and hypercoagulability. Although there is a definite connection, the assessment and management of this condition are still a subject of debate due to inconsistent research findings on its impact in lowering the risk of cardiovascular disease. B vitamins are a collection of chemical compounds that play a crucial role in physiological function. However, the body does not produce them naturally and they need to be obtained from dietary intake. Vitamins B6, B9, and B12 are crucial in the metabolism of homocysteine. The cause of hyperhomocysteinemia is believed to be a deficiency of certain vitamins, particularly folate, B12, and B6, which are important for effectively recycling homocysteine in the methionine cycle. Vitamin B is intricately linked to both the homocysteine and cardiovascular disease (CVD) pathways.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.